Approval · Notice of Compliance 35671 · 2025
ACH-METHOTREXATE: Notice of Compliance 35671
Issued July 15, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35671
- Date
- July 15, 2025
- Company
- Accord Healthcare IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to Product Monograph (to align with CRP approved PM) . Update to package insert
- Canadian reference product
- PMS-METHOTREXATE (Pharmascience Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACH-METHOTREXATE | Not yet assigned | — |
Medicinal ingredients
- METHOTREXATE DISODIUM 2.5 MG per TAB